单孔内镜下腹外斜肌松解术:复杂腹壁疝修补的新辅助技术
本研究前瞻性评估单孔内镜下腹外斜肌松解术在复杂腹壁疝修补中的应用,包括9例患者(16侧松解)和3具新鲜冰冻尸体(4侧松解)。患者术前接受A型肉毒毒素注射,术中经20mm单孔切口完成松解,最大筋膜推进50mm/侧,无伤口感染、血肿或膨出并发症,无疝复发。该技术安全有效,组织损伤小,但需进一步量化推进效果和并发症。
要点
- 单孔内镜下腹外斜肌松解术经20mm单孔切口完成,最大筋膜推进50mm/侧
- 术前A型肉毒毒素注射可辅助关闭复杂腹壁疝缺损
- 无伤口感染、血肿或膨出并发症,无疝复发
核心结论
- 单孔内镜下腹外斜肌松解术可作为复杂腹壁疝修补的辅助技术,安全有效且组织损伤小。
研究设计与样本
- 前瞻性研究,纳入9例复发复杂腹壁疝患者(16侧松解)和3具新鲜冰冻尸体(4侧松解)。
- 患者术前接受A型肉毒毒素注射至侧腹斜肌,择期行腹腔镜修补时完成单孔内镜下腹外斜肌松解。
主要发现
- 单孔内镜下腹外斜肌松解术在脐水平最大筋膜推进50mm/侧。
- 未观察到伤口感染、血肿或松弛/膨出并发症。
- 所有患者均完成腹腔镜或腹腔镜-开腹-腹腔镜腹腔内补片修补,至今无疝复发。
关键数值与推荐
- 每侧腹部仅需一个20mm单孔切口。
- 最大筋膜推进50mm/侧(脐水平测量)。
临床怎么用
- 该技术可作为复杂腹壁疝修补的辅助手段,尤其适用于需关闭较大缺损的病例。
- 术前A型肉毒毒素注射可能有助于缺损关闭,但需进一步量化其获益。
局限性
- 样本量小(9例患者和3具尸体),需进一步详细量化推进效果和并发症。
- 术前A型肉毒毒素注射对闭合的辅助作用尚需对照研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Component separation (CS) is a technique which mobilizes flaps of innervated, vascularized tissue, enabling closure of large ventral hernia defects using autologous tissue. Disadvantages include extensive tissue dissection when creating these myofascial advancement flaps, with potential consequences of significant post-operative skin and wound complications. This study examines the benefit of a novel, ultra-minimally invasive single port anterior CS technique. METHODS: This was a prospective study of 16 external oblique (EO) releases performed in 9 patients and 4 releases performed in 3 fresh frozen cadavers. All patients presented with recurrent complex ventral hernias, and were administered preoperative Botulinum Toxin A to their lateral oblique muscles to facilitate defect closure. At the time of elective laparoscopic repair, patients underwent single port endoscopic EO release using a single 20-mm incision on each side of the abdomen. Measurements were taken using real-time ultrasound. Postoperatively, patients underwent serial examination and abdominal CT assessment. RESULTS: Single port endoscopic EO release achieved a maximum of 50-mm myofascial advancement per side (measured at the umbilicus). No complications involving wound infection, hematoma, or laxity/bulge have been noted. All patients proceeded to laparoscopic or laparoscopic-open-laparoscopic intraperitoneal mesh repair of their hernia, with no hernia recurrences to date. CONCLUSIONS: Single port endoscopic EO release holds potential as an adjunct in the repair of large ventral hernia defects. It is easy to perform, is safe and efficient, and entails minimal disruption of tissue planes and preserves abdominal wall perforating vessels. It requires only one port-sized incision on each side of the abdomen, thus minimizing potential for complications. Further detailed quantification of advancement gains and morbidity from this technique is warranted, both with and without prior administration of Botulinum Toxin A to facilitate closure.
引用
- Elstner KE, Read JW, Jacombs ASW, et al. Single port component separation: endoscopic external oblique release for complex ventral hernia repair. Surg Endosc. 2017. PMID: 29264755. doi:10.1007/s00464-017-5949-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。